Skip to main content
AAPL+0.45%NVDA-4.92%MSFT+1.35%GOOGL+2.49%AMZN+1.47%TSM-1.33%SPCX+2.83%AVGO+5.77%META-0.38%TSLA+0.29%LLY+1.06%BRK-B+0.57%SKHY-3.24%WMT+0.12%MU-2.78%JPM+0.29%AMD+6.03%V+0.01%XOM+1.63%JNJ+1.57%ASMLa-1.67%MA-0.18%ABBV+0.83%COST+0.71%1398.HK-0.63%0700.HK-2.64%KO+0.63%CVX+1.57%CSCO+0.92%PG+0.58%ORCL-0.70%UNH+0.64%GE-1.59%0939.HK-0.57%HD-0.19%BAC+0.03%3988.HK+0.32%INTC-0.68%1816.HK+0.65%0857.HK-0.50%AMAT-0.65%0005.HK-0.64%AP2d-0.70%HSBA.L-0.12%PM+1.64%1288.HK-0.73%NVS+0.38%MS+0.29%LRCX-0.18%AZN-0.37%NZDCHF+1.78%USDCHF+1.74%USDZAR+1.10%CHFJPY-1.02%USDTHB+1.00%EURCHF+0.95%NZDCAD+0.91%AUDCHF+0.90%GBPNZD-0.89%USDCAD+0.89%AUDNZD-0.87%CADCHF+0.86%GBPUSD-0.85%GBPCHF+0.84%GBPZAR+0.83%AUDUSD-0.83%EURNZD-0.82%EURZAR+0.80%EURUSD-0.79%NZDJPY+0.76%USDJPY+0.72%USDSEK+0.55%GBPTRY+0.41%AUDSGD-0.37%CHFSEK+0.36%NOKJPY-0.34%GBPHKD+0.32%AUDNOK-0.32%EURCNH-0.31%SGDJPY-0.30%EURHKD-0.30%USDDKK+0.30%GBPMXN-0.28%AUDDKK-0.26%EURSEK+0.25%USDTRY+0.25%USDNOK+0.24%NZDMXN-0.24%EURPLN-0.21%PLNJPY-0.20%USDSGD+0.19%USDILS+0.16%CADJPY-0.16%GBPJPY-0.15%AUDJPY-0.11%EURSGD-0.11%EURCAD+0.10%EURGBP+0.09%USDPLN+0.09%NZDUSD+0.08%GBPSGD-0.08%USDHKD+0.07%EURJPY-0.06%NZDSGD-0.06%EURNOK-0.06%EURAUD+0.06%AUDCAD+0.04%USDMXN+0.04%CHFNOK+0.04%USDCOP-0.04%EURCZK+0.03%GBPAUD-0.03%GBPCAD+0.01%USDCNH0.00%CHFSGD0.00%EURDKK0.00%COFFEE+3.54%GAGUSD-2.88%XAGUSD-2.88%XAUUSD-2.74%GAUUSD-2.74%XNGUSD+1.73%UKOIL+1.19%HG1-1.04%W1-1.03%SUGAR-1.03%USOIL+0.79%C1-0.68%BTCUSD-2.92%ETHUSD+40.05%USDTUSD+0.01%XRPUSD+42.66%SOLUSD+42.29%TRXUSDT-0.13%ZECUSDT-0.76%DOGEUSD+38.92%XMRUSDT-5.63%LINKUSD-1.71%XLMUSD-1.25%BCHUSDT-1.71%UNIUSD-3.14%LTCUSD+34.13%TONUSD+46.15%SUIUSD-2.76%HBARUSDT-2.96%TAOUSDT-3.51%AAVEUSD-5.70%ICPUSDT-1.46%DOTUSDT-1.42%ONDOUSDT-2.92%ARBUSDT-2.69%JUPUSDT+2.94%WLDUSDT-1.45%INJUSDT-1.61%ATOMUSDT+1.56%STXUSDT-5.23%PYTHUSDT+0.12%TIAUSDT-0.75%FETUSDT-1.49%SEIUSDT-2.79%IMXUSDT-3.77%OPUSDT-2.94%GRTUSDT-3.30%POLUSDT-2.73%WIFUSDT-2.19%IOTAUSDT+0.65%AXSUSDT-2.49%FARTCOINUSDT-3.70%EOSUSDT-1.74%DYDXUSDT-1.99%GALAUSDT-1.22%ORDIUSDT-1.64%NOTUSDT+1.27%RONINUSDT-7.68%AAPL+0.45%NVDA-4.92%MSFT+1.35%GOOGL+2.49%AMZN+1.47%TSM-1.33%SPCX+2.83%AVGO+5.77%META-0.38%TSLA+0.29%LLY+1.06%BRK-B+0.57%SKHY-3.24%WMT+0.12%MU-2.78%JPM+0.29%AMD+6.03%V+0.01%XOM+1.63%JNJ+1.57%ASMLa-1.67%MA-0.18%ABBV+0.83%COST+0.71%1398.HK-0.63%0700.HK-2.64%KO+0.63%CVX+1.57%CSCO+0.92%PG+0.58%ORCL-0.70%UNH+0.64%GE-1.59%0939.HK-0.57%HD-0.19%BAC+0.03%3988.HK+0.32%INTC-0.68%1816.HK+0.65%0857.HK-0.50%AMAT-0.65%0005.HK-0.64%AP2d-0.70%HSBA.L-0.12%PM+1.64%1288.HK-0.73%NVS+0.38%MS+0.29%LRCX-0.18%AZN-0.37%NZDCHF+1.78%USDCHF+1.74%USDZAR+1.10%CHFJPY-1.02%USDTHB+1.00%EURCHF+0.95%NZDCAD+0.91%AUDCHF+0.90%GBPNZD-0.89%USDCAD+0.89%AUDNZD-0.87%CADCHF+0.86%GBPUSD-0.85%GBPCHF+0.84%GBPZAR+0.83%AUDUSD-0.83%EURNZD-0.82%EURZAR+0.80%EURUSD-0.79%NZDJPY+0.76%USDJPY+0.72%USDSEK+0.55%GBPTRY+0.41%AUDSGD-0.37%CHFSEK+0.36%NOKJPY-0.34%GBPHKD+0.32%AUDNOK-0.32%EURCNH-0.31%SGDJPY-0.30%EURHKD-0.30%USDDKK+0.30%GBPMXN-0.28%AUDDKK-0.26%EURSEK+0.25%USDTRY+0.25%USDNOK+0.24%NZDMXN-0.24%EURPLN-0.21%PLNJPY-0.20%USDSGD+0.19%USDILS+0.16%CADJPY-0.16%GBPJPY-0.15%AUDJPY-0.11%EURSGD-0.11%EURCAD+0.10%EURGBP+0.09%USDPLN+0.09%NZDUSD+0.08%GBPSGD-0.08%USDHKD+0.07%EURJPY-0.06%NZDSGD-0.06%EURNOK-0.06%EURAUD+0.06%AUDCAD+0.04%USDMXN+0.04%CHFNOK+0.04%USDCOP-0.04%EURCZK+0.03%GBPAUD-0.03%GBPCAD+0.01%USDCNH0.00%CHFSGD0.00%EURDKK0.00%COFFEE+3.54%GAGUSD-2.88%XAGUSD-2.88%XAUUSD-2.74%GAUUSD-2.74%XNGUSD+1.73%UKOIL+1.19%HG1-1.04%W1-1.03%SUGAR-1.03%USOIL+0.79%C1-0.68%BTCUSD-2.92%ETHUSD+40.05%USDTUSD+0.01%XRPUSD+42.66%SOLUSD+42.29%TRXUSDT-0.13%ZECUSDT-0.76%DOGEUSD+38.92%XMRUSDT-5.63%LINKUSD-1.71%XLMUSD-1.25%BCHUSDT-1.71%UNIUSD-3.14%LTCUSD+34.13%TONUSD+46.15%SUIUSD-2.76%HBARUSDT-2.96%TAOUSDT-3.51%AAVEUSD-5.70%ICPUSDT-1.46%DOTUSDT-1.42%ONDOUSDT-2.92%ARBUSDT-2.69%JUPUSDT+2.94%WLDUSDT-1.45%INJUSDT-1.61%ATOMUSDT+1.56%STXUSDT-5.23%PYTHUSDT+0.12%TIAUSDT-0.75%FETUSDT-1.49%SEIUSDT-2.79%IMXUSDT-3.77%OPUSDT-2.94%GRTUSDT-3.30%POLUSDT-2.73%WIFUSDT-2.19%IOTAUSDT+0.65%AXSUSDT-2.49%FARTCOINUSDT-3.70%EOSUSDT-1.74%DYDXUSDT-1.99%GALAUSDT-1.22%ORDIUSDT-1.64%NOTUSDT+1.27%RONINUSDT-7.68%
NO

Novavax, Inc. (NVAX)

NASDAQ • Healthcare

$9.98
-$0.21 (-2.2%)
Market open

Last close at November 11, 2026 at 21:00 UTC

Open$10.28
Previous Close$9.98
Day Range$9.9 - $10.36
Avg. Volume (3M)6.6M
Market Cap$1.6B
52 Week Range
$6.2$13.39

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$68.2M100%
Gross Profitminus cost of goods$44.8M66%

In plain terms: out of every $100 in revenue, Novavax, Inc. currently loses $46.

Fundamentals & Financials

Revenue (TTM)
$411.6M
Net Income (TTM)
-$76.7M
EPS (TTM)
-$0.46
ROA (TTM)
-8.64%
Current Ratio
2.15

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+76.0%Q2 2026-$0.06
+15.8%Q3 2026-$0.32
+45.1%Q4 2026-$0.19

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +45.1%

Novavax topped consensus on both EPS and revenue in the third fiscal quarter of 2026 (period ended September 30, 2026), reported November 5, 2026, with EPS of -$0.19 topping the -$0.35 estimate by $0.16 as revenue of $68.3 million topped the $50.4 million estimate (+35.4%). On a year-over-year basis, revenue slipped 3% to about $68.3 million from roughly $70.4 million, while net income improved 85% to a loss of about $31.4 million from a loss of roughly $202.4 million, alongside EPS up 85% from -$1.25 a year ago. Profitability showed a gross margin of roughly 66% as gross profit reached about $44.8 million, while operating income was a loss of roughly $31.3 million, corresponding to an operating margin near -46%. Cash generation was negative, with operating cash flow of roughly -$91.6 million. For the next period, consensus calls for EPS of $0.07 on revenue of $123.2 million.

View full earnings history

About Novavax, Inc.

Novavax, Inc. develops and commercializes vaccines within the biotechnology sector, centered on preventing serious infectious diseases. The company trades on the NASDAQ Global Select Market under NVAX and generated $1.1 billion of revenue in FY2025, with its work spanning marketed and developing vaccine programs for several respiratory viruses.

Name
Novavax, Inc.
CEO
John Charles Jacobs
Industry
Healthcare
Year Founded
1987
Employees
749

Today's Snapshot

AI-generated

The session opened with NVAX 2.5% lower at 9.73, while its sector was flat.

Trading Volume

Below 10d avg (6.0M)

1.6M

vs S&P 500 Today

Strong Underperformance

-7.47%

Updated: November 12, 2026 at 15:47 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
NVAX exhibits bearish characteristics driven by negative momentum and distribution. Momentum indicators including a deep negative CCI and a negative MACD point toward selling pressure, and the stock trades under its short- and medium-term moving averages even as it sits roughly at the 200-day level. ADX shows only moderate trend strength and ATR reflects relatively high percent volatility, while on-balance volume is negative, signaling outsized selling. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$9.34 - $10.34
    Sell
  • RSI (14)42.50
    Neutral
  • Stochastic %K (14, 3, 3)40.67
    Neutral
  • MACD Level (12, 26)-0.21
    Sell
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.